Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

XAIR

Beyond Air Inc

Last Close
Sep 06 • 04:00PM ET
0.4100
Dollar change
-0.0254
Percentage change
-5.83 		%
Held by: VTI VXF IWC Scroll to Statements
Index- P/E- EPS (ttm)-1.63 Insider Own19.32% Shs Outstand45.90M Perf Week-6.82%
Market Cap19.07M Forward P/E- EPS next Y-0.71 Insider Trans3.33% Shs Float37.53M Perf Month-1.68%
Income-58.35M PEG- EPS next Q-0.28 Inst Own25.95% Short Float1.99% Perf Quarter-65.25%
Sales1.78M P/S10.72 EPS this Y44.07% Inst Trans10.16% Short Ratio0.89 Perf Half Y-76.02%
Book/sh0.35 P/B1.17 EPS next Y29.86% ROA-97.62% Short Interest0.75M Perf Year-87.07%
Cash/sh0.46 P/C0.88 EPS next 5Y- ROE-226.22% 52W Range0.36 - 3.32 Perf YTD-79.08%
Dividend Est.- P/FCF- EPS past 5Y-18.68% ROI-177.53% 52W High-87.65% Beta-0.11
Dividend TTM- Quick Ratio2.42 Sales past 5Y-43.84% Gross Margin-125.10% 52W Low15.17% ATR (14)0.05
Dividend Ex-Date- Current Ratio2.63 EPS Y/Y TTM15.47% Oper. Margin-3405.05% RSI (14)39.52 Volatility9.09% 12.78%
Employees107 Debt/Eq1.10 Sales Y/Y TTM2922.03% Profit Margin-3272.46% Recom1.40 Target Price3.75
Option/ShortYes / Yes LT Debt/Eq1.04 EPS Q/Q40.81% Payout- Rel Volume0.20 Prev Close0.44
Sales Surprise-14.41% EPS Surprise14.80% Sales Q/Q1057.63% EarningsAug 06 AMC Avg Volume838.78K Price0.41
SMA20-6.13% SMA50-20.73% SMA200-67.96% Trades Volume166,344 Change-5.83%
Date Action Analyst Rating Change Price Target Change
Jun-25-24Downgrade BTIG Research Buy → Neutral
Jul-28-23Initiated Piper Sandler Overweight $10
Jun-15-23Initiated BTIG Research Buy $15
Apr-28-21Initiated Truist Buy $12
Oct-22-19Initiated Oppenheimer Outperform $9
Aug-06-24 04:05PM
Beyond Air® Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate Update
(GlobeNewswire) -17.38%
Jul-31-24 04:15PM
Beyond Air Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia
(GlobeNewswire) -5.16%
Jul-23-24 04:05PM
Beyond Air to Report First Fiscal Quarter 2025 Financial Results on August 6
(GlobeNewswire) +5.29%
Jul-16-24 04:05PM
Beyond Air To Participate in the BTIG Virtual Biotechnology Conference 2024
(GlobeNewswire)
Jul-10-24 09:55AM
Beyond Air (XAIR) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
(Zacks) +5.59%
08:01AM Loading…
Jun-26-24 08:01AM
Beyond Air, Inc. (NASDAQ:XAIR) Q4 2024 Earnings Call Transcript
(Insider Monkey)
Jun-25-24 10:31AM
Jefferies Just Raised Its Price Target on Nvidia (NVDA) Stock
(InvestorPlace) -51.54%
08:28AM
Why Is Beyond Air (XAIR) Stock Down 22% Today?
(InvestorPlace)
07:37AM
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
(InvestorPlace)
Jun-24-24 08:53PM
XAIR Stock Earnings: Beyond Air Beats EPS, Misses Revenue for Q4 2024
(InvestorPlace) +8.06%
05:25PM
Beyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates
(Zacks)
04:15PM
Beyond Air Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
(GlobeNewswire)
Jun-13-24 04:05PM
Beyond Air Appoints David Webster as Chief Commercial Officer
(GlobeNewswire)
Jun-03-24 07:00AM
Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)
(GlobeNewswire) -8.59%
May-23-24 04:09PM
Beyond Air Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast
(GlobeNewswire) -9.50%
07:00AM Loading…
May-01-24 07:00AM
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting
(GlobeNewswire)
Mar-21-24 12:00PM
Beyond Air (XAIR) Upgraded to Buy: What Does It Mean for the Stock?
(Zacks) +5.84%
Mar-20-24 09:00AM
Beyond Air Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
(GlobeNewswire)
Feb-13-24 08:51AM
Beyond Air, Inc. (NASDAQ:XAIR) Q3 2024 Earnings Call Transcript
(Insider Monkey) -17.67%
Feb-12-24 04:05PM
Beyond Air Reports Financial Results for Third Quarter of Fiscal Year 2024
(GlobeNewswire) +14.97%
Jan-18-24 08:00AM
Beyond Air Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast
(GlobeNewswire) -5.02%
Dec-27-23 07:30AM
Beyond Cancer Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors
(GlobeNewswire)
Dec-21-23 01:40AM
Insider Buying: CEO Steven Lisi Acquires 77,775 Shares of Beyond Air Inc
(GuruFocus.com) +12.04%
Nov-15-23 04:05PM
Beyond Air To Participate in the 35th Annual Piper Sandler Healthcare Conference
(GlobeNewswire) +23.57% -8.96%
Nov-14-23 10:00AM
Beyond Air, Inc. (NASDAQ:XAIR) Q2 2024 Earnings Call Transcript
(Insider Monkey) -31.03%
Nov-13-23 04:05PM
Beyond Air Reports Financial Results for Second Quarter of Fiscal Year 2024
(GlobeNewswire)
Nov-03-23 12:00PM
Beyond Cancer Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
(GlobeNewswire) -6.91%
Oct-19-23 04:05PM
Beyond Air Schedules Second Fiscal Quarter 2024 Financial Results Conference Call and Webcast
(GlobeNewswire)
Oct-17-23 04:05PM
Beyond Air To Participate in the Truist Securities BioPharma Symposium
(GlobeNewswire) +8.48% -6.17%
07:30AM
Beyond Cancer Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide (UNO) and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival in Mice
(GlobeNewswire)
07:30AM Loading…
Oct-16-23 07:30AM
Beyond Cancer Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
(GlobeNewswire)
07:00AM
Beyond Air Receives Innovative Technology Contract from Vizient for LungFit PH
(GlobeNewswire)
Oct-04-23 07:30AM
Beyond Cancer Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
(GlobeNewswire)
Oct-02-23 04:05PM
Beyond Air To Participate in the Roth MKM 2023 Healthcare Opportunities Conference
(GlobeNewswire) -7.79%
Sep-27-23 09:00AM
Beyond Cancer to Present Initial Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2023 SITC Annual Meeting
(GlobeNewswire)
Sep-18-23 04:05PM
Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder
(GlobeNewswire) -7.95% +6.83%
Sep-07-23 07:30AM
Beyond Air® and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific Region
(GlobeNewswire)
Sep-06-23 07:00AM
Beyond Air® To Participate in the 2023 Cantor Global Healthcare Conference
(GlobeNewswire)
Aug-10-23 04:05PM
Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2024
(GlobeNewswire)
Aug-08-23 09:55AM
2 Strong Buy Penny Stocks That Could Rally All the Way to $10 (or More)
(TipRanks) +13.35%
Aug-07-23 04:05PM
Beyond Air® Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder (ASD)
(GlobeNewswire)
Aug-01-23 04:05PM
Beyond Air® To Participate in BTIGs 2023 Virtual Biotechnology Conference
(GlobeNewswire)
Jul-28-23 10:13AM
Block upgraded, Southwest downgraded: Wall Street's top analyst calls
(The Fly) +7.12%
Jul-24-23 04:05PM
Beyond Air® Schedules First Fiscal Quarter 2024 Financial Results Conference Call and Webcast
(GlobeNewswire) -6.11% -5.42%
Jun-22-23 04:05PM
Beyond Air® Reports Financial Results for Fourth Quarter and Fiscal Year-End 2023
(GlobeNewswire) -18.84%
Jun-15-23 04:10PM
Beyond Air® Secures up to $40 Million Debt Financing
(GlobeNewswire)
04:05PM
Beyond Air® Licenses Commercial Rights to Selective Neuronal Nitric Oxide Synthase (nNOS) Inhibitors for the Treatment of Autism Spectrum Disorder from Hebrew University of Jerusalem
(GlobeNewswire)
Jun-09-23 06:34AM
Daily Vickers Top Insider Picks for 06/09/2023
(Argus Research)
Jun-08-23 06:43AM
Daily Vickers Top Insider Picks for 06/08/2023
(Argus Research)
Jun-07-23 08:25AM
Daily Vickers Top Insider Picks for 06/07/2023
(Argus Research)
Jun-06-23 06:34AM
Daily Vickers Top Insider Picks for 06/06/2023
(Argus Research)
Jun-05-23 06:44AM
Daily Vickers Top Insider Picks for 06/05/2023
(Argus Research)
Jun-02-23 06:56AM
Daily Vickers Top Insider Picks for 06/02/2023
(Argus Research)
Jun-01-23 06:29AM
Daily Vickers Top Insider Picks for 06/01/2023
(Argus Research)
May-31-23 06:40AM
Daily Vickers Top Insider Picks for 05/31/2023
(Argus Research)
May-30-23 06:50AM
Daily Vickers Top Insider Picks for 05/30/2023
(Argus Research)
May-26-23 06:59AM
Daily Vickers Top Insider Picks for 05/26/2023
(Argus Research)
May-25-23 06:38AM
Daily Vickers Top Insider Picks for 05/25/2023
(Argus Research)
May-24-23 06:43AM
Daily Vickers Top Insider Picks for 05/24/2023
(Argus Research)
May-23-23 06:33AM
Daily Vickers Top Insider Picks for 05/23/2023
(Argus Research)
May-22-23 07:49AM
Daily Vickers Top Insider Picks for 05/22/2023
(Argus Research)
May-19-23 07:03AM
Daily Vickers Top Insider Picks for 05/19/2023
(Argus Research)
May-18-23 06:39AM
Daily Vickers Top Insider Picks for 05/18/2023
(Argus Research)
May-17-23 06:35AM
Daily Vickers Top Insider Picks for 05/17/2023
(Argus Research)
May-16-23 04:05PM
Beyond Air® Schedules Fiscal Year End 2023 Financial Results Conference Call and Webcast
(GlobeNewswire)
Apr-19-23 09:00AM
Beyond Cancer Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the American Association for Cancer Research (AACR) 2023 Annual Meeting
(GlobeNewswire)
Mar-31-23 06:36AM
Daily Vickers Top Buyers & Sellers for 03/31/2023
(Argus Research)
Mar-23-23 04:05PM
Beyond Air® Appoints Jeff Myers, M.D. Ph.D. as Chief Medical Officer
(GlobeNewswire) -5.84%
Mar-14-23 04:35PM
Beyond Cancer to Present Two Posters for Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2023 AACR Annual Meeting
(GlobeNewswire) +6.59%
Mar-10-23 07:04AM
Daily Vickers Top Buyers & Sellers for 03/10/2023
(Argus Research)
Feb-22-23 07:00AM
Beyond Air® Announces Participation at Two Upcoming Investor Conferences in March 2023
(GlobeNewswire)
Feb-09-23 04:05PM
Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2023
(GlobeNewswire) -6.21% -7.83%
Jan-30-23 07:00AM
Beyond Cancer® Appoints Gavin Choy, PharmD as Chief Operating Officer
(GlobeNewswire)
Jan-24-23 04:05PM
Beyond Cancer® Announces Sponsored Research Agreement with Stanford and Appointment of Frederick M. Dirbas, MD and Mark D. Pegram, MD to Scientific Advisory Board
(GlobeNewswire)
Jan-17-23 04:05PM
Beyond Air® Schedules Third Fiscal Quarter 2023 Financial Results Conference Call and Webcast
(GlobeNewswire)
Dec-13-22 09:25AM
Beyond Cancer® Publishes Pre-Clinical Data in Cancer Cell International Demonstrating Its Tumor Ablation Method Utilizing Ultra-High Concentration Nitric Oxide (UNO) Induced a Systemic Response that Prevents Metastases
(GlobeNewswire) +9.26%
Nov-17-22 04:05PM
Beyond Air® To Participate in Pipers 34th Annual Healthcare Conference
(GlobeNewswire) -6.08%
Nov-10-22 09:00AM
Beyond Cancer Presents Promising New In Vivo Data Showing Ultra-High Concentration Nitric Oxide Therapy (UNO) in Combination with Anti-PD-1 During the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting
(GlobeNewswire)
Nov-08-22 04:05PM
Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2023
(GlobeNewswire) -16.87%
Oct-24-22 07:30AM
Beyond Air® Announces Positive Data for Inhaled Nitric Oxide (NO) to Treat COVID-19 with LungFit® PRO in a Poster Presentation at IDWeek 2022
(GlobeNewswire)
Oct-20-22 04:05PM
Beyond Air® Schedules Second Fiscal Quarter 2023 Financial Results Conference Call and Webcast
(GlobeNewswire) +7.55%
Oct-17-22 04:05PM
Beyond Air® Announces Positive Data from At-Home Pilot Study in Patients with Refractory NTM Lung Infection Treated with (NO) using the LungFit® GO at the CHEST Annual Meeting 2022
(GlobeNewswire) +29.85%
Oct-05-22 08:00AM
Beyond Cancer to Present Pre-Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2022 SITC Annual Meeting
(GlobeNewswire)
Oct-03-22 07:30AM
Beyond Air® Announces that Annals of the American Thoracic Society Published a Review of the Third Pilot Study of High Dose Nitric Oxide for Bronchiolitis
(GlobeNewswire)
Sep-16-22 04:05PM
Beyond Air® To Participate in Three Upcoming Investor Conferences
(GlobeNewswire)
Aug-23-22 08:00AM
Beyond Air® Affiliate Beyond Cancer Doses Initial Patient in First-in-Human Phase 1 Study of Ultra-High Concentration Nitric Oxide Therapy at Tel Aviv Sourasky Medical Center (Ichilov)
(GlobeNewswire) +10.12%
Aug-11-22 04:05PM
Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2023
(GlobeNewswire) +8.07%
Jul-27-22 04:05PM
Beyond Air® Schedules First Fiscal Quarter 2023 Financial Results Conference Call and Webcast
(GlobeNewswire)
Jun-28-22 04:10PM
Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2022
(GlobeNewswire) -7.81% +8.13%
04:05PM
Beyond Airs LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure
(GlobeNewswire)
Jun-14-22 04:30PM
Beyond Air® Announces Fiscal Year End 2022 Financial Results Conference Call and Webcast Moved to Tuesday, June 28th
(GlobeNewswire) +9.84%
Jun-01-22 07:00AM
Beyond Cancer Announces the Appointment of Jedidiah Monson, M.D. to Chief Medical Officer
(GlobeNewswire)
May-17-22 04:05PM
Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022
(GlobeNewswire) +7.84%
07:00AM
Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer
(GlobeNewswire)
May-16-22 07:05AM
Beyond Air® Schedules Fiscal Year 2022 Financial Results Conference Call and Webcast
(GlobeNewswire)
May-06-22 06:29AM
Loss-Making Beyond Air, Inc. (NASDAQ:XAIR) Expected To Breakeven In The Medium-Term
(Simply Wall St.)
Apr-25-22 04:05PM
Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022
(GlobeNewswire) +12.02%
07:00AM
Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022
(GlobeNewswire)
Apr-18-22 07:00AM
Beyond Air® to Participate in Three Upcoming Medical Conferences
(GlobeNewswire)
Apr-11-22 07:00AM
Beyond Cancer Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect
(GlobeNewswire) -7.95%
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Avniel AmirOfficerAug 22 '24Proposed Sale0.46180,41583,442Aug 22 10:13 AM
Lisi Steven A.CEO and Chairman of the BoardAug 15 '24Buy0.3750,00018,3401,772,785Aug 19 06:06 AM
Lucera ErickDirectorAug 14 '24Buy0.4039,26615,56543,608Aug 15 05:09 PM
Carey RobertDirectorAug 14 '24Buy0.40100,00039,6803,076,864Aug 15 05:09 PM
Lisi Steven A.CEO and Chairman of the BoardAug 14 '24Buy0.39100,00038,6401,722,785Aug 15 05:09 PM
Avniel AmirChief Business OfficerDec 28 '23Sale2.0513,73328,2170Dec 29 04:23 PM
Avniel AmirChief Business OfficerDec 28 '23Sale2.0611,26723,234685,760Dec 29 04:23 PM
Myers Jeff LynnChief Medical OfficerDec 27 '23Sale2.213,4237,57946,577Dec 29 04:15 PM
Lisi Steven A.CEO and Chairman of the BoardDec 18 '23Buy1.6377,775126,7971,536,471Dec 19 05:15 PM
Carey RobertDirectorDec 18 '23Buy1.641,200,0001,962,0002,374,454Dec 19 05:13 PM
Gaul Michael A.Chief Operating OfficerNov 16 '23Buy1.7710,00017,70088,150Nov 17 04:15 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.